Comparison of different medical treatments for primary hyperaldosteronism: a systematic review and network meta-analysis

CONCLUSION: The present NMA indicated that the blood pressure reduction and potassium-correcting effects of the three MRAs may demonstrate marginal differences, with confidence levels in the evidence being very low. Therefore, further research is needed to explore the efficacy of these MRAs, especially regarding their impact on mortality and cardiovascular outcomes.TRIAL REGISTRATION: PROSPERO (CRD: 42023446811).PMID:38511069 | PMC:PMC10953100 | DOI:10.1177/20406223241239775

Source: Adv Data - March 21, 2024 Category: Epidemiology Authors: Wen-Yu Ho Ching-Chung Hsiao Ping-Hsun Wu Jui-Yi Chen Yu-Kang Tu Vin-Cent Wu Jia-Jin Chen Source Type: research